Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT01472926
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 104 participants
- Registry
-
NCT01472926 -
2010-024541-67
-
- Other papers using this trial's data
- Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study
- Coagulation and Fibrinolytic Activity of Tenecteplase and Alteplase in Acute Ischemic Stroke
- Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01472926. Randomized; single masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-12-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis- (ATTEST)
- Acronym
- ATTEST
- Condition
- Stroke
- Intervention (Drug)
- Tenecteplase
- Intervention (Drug)
- alteplase
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Collaborator
- University of Glasgow
Record details
- Record id
cardio:ct-nct01472926- Content hash
0c7d9ef445319fbd7dc95ca5f77746eb10be6a1ab575b7fa598a9ade1f970323